Drug Profile
Research programme: hybrid virus vaccines - CDC/NIAID/Takeda
Alternative Names: Combination plague/smallpox vaccine - CDC/NIAID/Takeda; Plague (Y. pestis) vaccine - CDC/NIAID/Takeda; WNVax - CDC/NIAID/TakedaLatest Information Update: 23 Jul 2014
Price :
$50
*
At a glance
- Originator Centers for Disease Control and Prevention; InViragen LLC; National Institute of Allergy and Infectious Diseases
- Developer Advanced BioScience Laboratories; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; Takeda Pharmaceuticals USA
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Smallpox; West Nile virus infections; Yersinia infections
Most Recent Events
- 23 Jul 2014 No development reported - Preclinical for Smallpox in USA (Injection)
- 23 Jul 2014 No development reported - Preclinical for West Nile virus infections in USA (unspecified route)
- 23 Jul 2014 No development reported - Preclinical for Yersinia infections in USA (unspecified route)